Source link : https://www.newshealth.biz/health-news/tirzepatide-slashes-progression-from-prediabetes-to-t2d/
SAN ANTONIO – Once-weekly tirzepatide (Zepbound) reduced the risk for progression from prediabetes to type 2 diabetes (T2D) by more than 90% at 3 years and continued to maintain dramatic levels of weight loss achieved earlier, but these benefits began reversing when the drug was stopped. The findings, from the subset of 1032 individuals with […]
Author : News Health
Publish date : 2024-11-05 16:27:05
Copyright for syndicated content belongs to the linked Source.